ARTICLE INFO

Article Type

Original Research

Authors

Abbasnezhad   A.A. (1)
Niyazmand   S. (*)
Mahmoud Abadi   M. (1)
Soukhtanloo   M. (2)
Rezaee   S.A. (3 )
Mousavi   S.M. (1)






(*) Physiology Department, Medicine Faculty, Mashhad University of Medical Sciences, Mashhad, Iran
(1) Physiology Department , Medicine Faculty, Mashhad University of Medical Sciences, Mashhad, Iran
(1) Physiology Department, Medicine Faculty, Mashhad University of Medical Sciences, Mashhad, Iran
(1) Physiology Department , Medicine Faculty, Mashhad University of Medical Sciences, Mashhad, Iran
(2) Biochemistry Department, Medicine Faculty, Mashhad University of Medical Sciences, Mashhad, Iran
(3 ) Immunology Department, Medicine Faculty, Mashhad University of Medical Sciences, Mashhad, Iran

Correspondence

Address: Physiology Department, Medicine Faculty, Mashhad University of Medical Sciences, Azadi Square, Mashhad, Iran
Phone: +985138002225
Fax: +985138828564
niazmands@mums.ac.ir

Article History

Received:  October  19, 2014
Accepted:  December 29, 2014
ePublished:  February 19, 2015

BRIEF TEXT


… [1-7] Nigella Sativa L. from Ranunculaceae family is a medicinal herb used widely for medication purposes. Thymoquinone (with maximum medication activity), dithymoquinone, thymohydroquinone, and thymol are the main effective materials of the hydro-alcoholic extract of Nigella Sativa L. The seed of Nigella Sativa L. includes lipid, proteins, vitamins, minerals, and carbohydrates [8].

Blood sugar reduction, lipid and blood pressure increases, and anti-inflammation, anti-histamine, anti-microbial, and anti-parasite effects are some medication effects of the extract of the seed of Nigella Sativa L. and it reinforces the immune system and protects different body tissues [9].

The aim of this study was to investigate the effects of hydro-alcoholic extract of Nigella Sativa L. on blood biochemical parameters in the streptozotocin-induced diabetic male rats.

This is an intervention study.

250-300gr Wistar male rats (Animal House; Mashhad University of Medical Sciences, Iran) were studied in 2013-14.

60 rats were studied.

The animals were randomly divided into six 10-sample groups including “Control (C)”, “Diabetes (D)”, “Receiving 100mg/kg Extract (E100)”, “Receiving 200mg/kg Extract (E200)”, “Receiving 400mg/kg Extract (E400)”, and “Positive Control (M)”. The animals were kept at standard conditions at 22±2°C and 12-hour light-darkness cycle and in the animal room. Hydro-alcoholic extract was produced, using maceration method. Control group received saline daily and during 6 weeks from the beginning of the study. 60mg/kg single dose of streptozotcin (Sigma; Germany) were administrated as intra-peritoneal [10]. If glucose level was higher than 250mg/dl during 48 hours after injection, the group received saline daily and as gavage for 6 weeks during the remaining of the study. The extract groups received the determined doses of the extract as gavage from the onset of diabetes for 6 weeks. Positive control group received 300mg/kg metformin (Samen; Iran) daily and as gavage from the onset of diabetes for 6 weeks. In all groups, blood taking was done on the ocular sinus on the onset day (day zero) and 24th and 45th days after the beginning of the study and following 12-hour fasting. Glucose, cholesterol, triglyceride, HDL, and LDL were measured by a kit (Pars Azmoon; Iran). Glucose level measured again at the 3rd day. Data was analyzed, using SPSS 16 software. One-way ANOVA (to compare the biochemical parameters of blood), Tukey Post-hoc (to compare glucose, cholesterol, triglyceride, HDL, and LDL levels in the groups), and Paired-T test (to compare HDL concentration at day 45 with day zero) were used. … [11]

During the experiment, there was a significant increase in the blood glucose level in diabetic group than control group. In the diabetic groups treated with metformin and extract of Nigella Sativa L. it decreased from day 3 to day 45. Reduction in the blood sugar level in the diabetic group receiving 200mg/kg of extract of Nigella Sativa L. was significantly more than other treatment groups (Diagram 1). There was a significant increase in the blood cholesterol concentration in the diabetic group than control group at days 24 and 45. There was a significant reduction in the blood cholesterol concentration in the diabetic groups treated by metformin and extract of Nigella Sativa L. gradually from day 24 to day 45 than diabetic group. Nevertheless, there was no significant difference between the treated groups (Diagram 2). There was a significant increase in the blood triglyceride concentration in diabetic group than control group at days 24 and 45. There was a gradual reduction in triglyceride concentration in the diabetic groups treated with metformin and extract of Nigella Sativa L. from day 24 to day 45, and maximum and minimum reductions were in metformin group and group receiving 100 doses of the extract (Diagram 3). There was no significant difference in HDL concentration in the groups. There was a significant reduction in HDL concentration in diabetic group at day 45 than day zero (Diagram 4). There was a gradual increase in LDL concentration in diabetic group. In addition, there was a significant increase at day 45 than control group. There was a significant reduction in LDL concentration in the diabetic groups treated by metformin and extract of Nigella Sativa L. at day 45 than diabetic group (Diagram 5).

There was a reduction in blood glucose level in the diabetic groups treated by metformin and extract of Nigella Sativa L. gradually from day 3 to day 45. And there was more reduction in blood glucose level in diabetic group receiving 200mg/kg extract of Nigella Sativa L. than other treated groups. Administration of Nigella Sativa L. for the diabetic animals reduces blood glucose [12, 13]. … [14-25] The extract of Nigella Sativa L. reduced blood LDL, triglyceride, and cholesterol levels after 6 weeks. There was a lesser reduction in blood HDL level than diabetic group, and it approximately stopped at the doses 200 and 400. Maximum reduction in LDL/HDL was in 400 extract group among other treated diabetic groups. Oral administration of the extract of Nigella Sativa L. for the diabetic rats results in a natural blood glucose, and it significantly reduces plasma lipid level, while it increases plasma insulin level compared with untreated diabetic group [26]. After 8 weeks, there are significant reductions in cholesterol and LDL levels and an increase in HDL in hyperlipidemia rabbits due to Nigella Sativa L. compared with positive control group [27]. 225mg/kg doses of extract of Nigella Sativa L. significantly affect glucose, triglyceride, and cholesterol [28]. There is an increase in HDL level in insulin resistance syndrome and reductions in fasting blood sugar, total cholesterol, and LDL levels due to Nigella Sativa L. [29]. There were significant reductions in cholesterol, LDL, and triglyceride levels in the diabetic rats due to metformin, while it had no effect on HDL level. Despite significant reductions in cholesterol and LDL levels due to metformin in diabetes, it has had no significant effect on triglyceride and HDL [30].

Treatment duration should be investigated.

There was no limitation.

The extract of Nigella Sativa L. reduces plasma LDL, glucose, cholesterol, and triglyceride levels in the diabetic rats.

Research Deputy of Mashhad University of Medical Sciences and the staff of Medicinal Plants Research Center of Medicine Faculty are appreciated.

Non-declared

Medical Ethics Committee of Mashhad University of Medical Sciences confirmed the study.

Deputy of Mashhad University of Medical Sciences funded the study.  

TABLES and CHARTS

Show attach file


CITIATION LINKS

[1]Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.
[2]Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49(7):571-6.
[3]Momin M, Momin S, Kurhade S, Butte K. Niglla sativa: Blessed seed. Res Phyochem Pharmachol. 2013;3(2):78-84.
[4]Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Therapy. 2008;88(11):1254-64.
[5]Yan SH, Sheu WH, Song YM, Tseng LN. The occurrence of diabetic ketoacidosis in adults. Am J Med. 1996;101(1):19-24.
[6]American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):62-9.
[7]Dattner AM. From medical herbalism to phytotherapy in dermatology: back to the future. Dermatol Ther. 2003;16(2):106-13.
[8]Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013;3(5):337-52.
[9]Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17(4):299-305.
[10]Frode TS, Medeiros YS. Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol. 2008;115(2):173-83.
[11]Bell RH Jr, Hye RJ. Animal models of diabetes mellitus: Physiology and pathology. J Surg Res. 1983;35(5):433-60.
[12]Houcher Z, Boudiaf K, Benboubetra M, Houcher B. Effects of methanolic extract and commercial oil of Nigella sativa L. on blood glucose and antioxidant capacity in alloxan-induced diabetic rats. Pteridines. 2007;18(1):8-18.
[13]Hawsawi ZA, Ali BA, Bamosa AO. Effect of Nigella sativa (black seed) and thymoquinone on blood glucose in albino rats. Ann Saudi Med. 2001;21(3-4):242-4.
[14]Bhat M, Zinjarde SS, Bhargava SY, Kumar AR, Joshi BN. Antidiabetic Indian plants: A good source of potent amylase inhibitors Evid Based Complement Alternat Med. 2011;2011:810207.
[15]Luo JZ, Luo L. Ginseng on hyperglycemia: effects and mechanisms. Evid Based Complement Alternat Med. 2009;6(4):423-7.
[16]Samane S, Noel J, Charrouf Z, Amarouch H, Haddad PS. Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts. Evid Based Complement Alternat Med. 2006;3(3):317-27.
[17]Meddah B, Ducroc R, El Abbes Faouzi M, Eto B, Mahraoui L, Benhaddou-Andaloussi A, et al. Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J Ethnopharmacol. 2009;121(3):419-24.
[18]Fararh K, Atoji Y, Shimizu Y, Shiina T, Nikami H, Takewaki T. Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Res Vet Sci. 2004;77(2):123-9.
[19]Benhaddou-Andaloussi A, Martineau L, Vuong T, Meddah B, Madiraju P, Settaf A, et al. The In Vivo Antidiabetic Activity of Nigella sativa Is Mediated through Activation of the AMPK Pathway and Increased Muscle Glut4 Content. Evid Based Complement Alternat Med. 2011;2011:538671
[20]Al-Logmani A, Zari T. Long-term effects of Nigella sativa L. oil on some physiological parameters in normal and streptozotocin-induced diabetic rats. J Diabetes Mellitus. 2011;1(3):46-53.
[21]Saleh DO, Bayoumi AR, El-Eraky WI, El-Khatib AS. Streptozotocin-induced vascular and biochemical changes in rats: Effects of rosiglitazone vs. metformin. Bull Faculty Pharm Cairo Univ. 2013;51(2):131-8.
[22]Beisswenger P, Ruggiero-Lopez D. Metformin inhibition of glycation processes. 2003;29(4 Pt 2):6S95-103
[23]Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care. 1990;13(6):696-704.
[24]Zhou G1, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167-74.
[25]Kannel WB. Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study. Am Heart J. 1985;110(5):1100-7.
[26]Kaleem M, Kirmani D, Asif M, Ahmed Q, Bano B. Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J Exp Biol. 2006;44(9):745-8.
[27]Al-Naqeep G, Al-Zubairi AS, Ismail M, Amom ZH, Esa NM. Antiatherogenic potential of Nigella sativa seeds and oil in diet-induced hypercholesterolemia in rabbits. Evid Based Complement Alternat Med. 2011;2011:213628.
[28]Hadjzadeh M-AL-R , Pilavarian AA, Hydari AA, Behnam Rassouli F. The effect of aqueous extract of Niglla sativa L. Seeds in streptozocin induced diabetic rat. Pharmacologyonline. 2008;3:986-91.
[29]Najmi A, Nasiruddin M, Khan RA, Haque SF. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int J Diabetes Dev Ctries. 2008;28(1):11-4.
[30]Pentikainen PJ, Voutilainen E, Aro A, Uusitupa M, Penttila I, Vapaatalo H. Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial. Ann Med. 1990;22(5):307-12.